Brief: Sirnaomics Says Rnaimmune Receives IND Application Clearance From U.S. FDA
18/12/2023 16:32
Dec 18 (Reuters) - Sirnaomics Ltd 2257.HK :
* RNAIMMUNE RECEIVES INVESTIGATIONAL NEW DRUG APPLICATION
CLEARANCE FROM U.S. FDA
* CLEARANCE FROM U.S. FDA FOR MRNA-BASED RESPIRATORY
SYNCYTIAL
VIRUS VACCINE RV-1770
Further company coverage: 2257.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sirnaomics
See all newsBrief: Sirnaomics Announces RMB30 Million Capital Injection For Deemed Disposal
Brief: Sirnaomics And Unit Files Writ Of Summons Against Former Management
Brief: Sirnaomics To Issue 2.4 Million New Shares At Hk$4.69 Each Under General Mandate
Brief: Sirnaomics Says Chairman Purchases 38,000 Shares At Average Price Hk$5.93 Per Share
Brief: Sirnaomics Ltd To Issue 17.4 Million Subscription Shares